Tissue Culture Shared Resource

Home | Services & Fees | Educational Resources | Publications | Schedule


2003 2004 2005 2006 2007 2008 2009 2010 2011 2012


An Y, Bekesova S, Edwards N, Goldman R. Peptides in low molecular weight fraction of serum associated with hepatocellular carcinoma. Dis Markers. 2010;29(1):11-20. 20826913

Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res. 2010 Dec 1;70(23):9742- 54 21118973 2999830

Astsaturov I, Ratushny V, Sukhanova A, Einarson MB, Bagnyukova T, Zhou Y, Devarajan K, Silverman JS, Tikhmyanova N, Skobeleva N, Pecherskaya A, Nasto RE, Sharma C, Jablonski SA, Serebriiskii IG, Weiner LM, Golemis EA. Synthetic lethal screen of an EGFR-centered network to improve targeted therapies. Sci Signal. 2010 Sep 21;3(140):ra67. 20858866 2950064

Awad O, Yustein JT, Shah P, Gul N, Katuri V, O'Neill A, Kong Y, Brown ML, Toretsky JA, Loeb DM. High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWSFLI1 inhibition. PLoS One. 2010 Nov 11;5(11):e13943. 21085683 2978678 12

Balaburski, G.M., Dardes, R.C., Johnson, M.D., Haddad, B., Zhu, F., Ross, E.A., Sengupta, S., Klein- Szanto, A., Liu, H., Lee, E.S., Kim, H., Jordan, V.C. Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in antihormone resistance Int J Oncol. 2010 Aug;37(2):387-98. 20596666 3023309

Broustas CG, Ross JS, Yang Q, Sheehan CE, Riggins R, Noone AM, Haddad BR, Seillier- Moiseiwitsch F, Kallakury BV, Haffty BG, Clarke R, Kasid UN. The proapoptotic molecule BLID interacts with Bcl-XL and its downregulation in breast cancer correlates with poor disease-free and overall survival. Clin Cancer Res. 2010 Jun 1;16(11):2939-48. Epub 2010 Apr 16. 20400521

Cha H, Lowe JM, Li H, Lee JS, Belova GI, Bulavin DV, Fornace AJ Jr. Wip1 directly dephosphorylates gamma- H2AX and attenuates the DNA damage response. Cancer Res. 2010 May 15;70(10):4112-22. doi: 10.1158/0008- 5472.CAN-09-4244. Epub 2010 May 11. 20460517

Chapman S, Liu X, Meyers C, Schlegel R, McBride AA. Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest. 2010 Jul;120(7):2619-26. doi: 10.1172/JCI42297. 20516646 2898606

Cheema A, Knights CD, Rao M, Catania J, Perez R, Simons B, Dakshanamurthy S, Kolukula VK, Tilli M, Furth PA, Albanese C, Avantaggiati ML. Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD. J Cell Physiol. 2010 Nov;225(2):371-84. doi: 10.1002/jcp.22224. 20458745

Chen YW, Lee MS, Lucht A, Chou FP, Huang W, Havighurst TC, Kim K, Wang JK, Antalis TM, Johnson MD, Lin CY. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. Am J Pathol. 2010 Jun;176(6):2986-96. Epub 2010 Apr 9.
20382709 2877858

Chen YW, Wang JK, Chou FP, Chen CY, Rorke EA, Chen LM, Chai KX, Eckert RL, Johnson MD, Lin CY. Regulation of the matriptaseprostasin cell surface proteolytic cascade by hepatocyte growth factor activator inhibitor-1 during epidermal differentiation. J Biol Chem. 2010 Oct 8;285(41):31755-62. Epub 2010 Aug 9. 20696767 2951247

Crawford AC, Riggins RB, Shajahan AN, Zwart A, Clarke R. Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagyassociated necrosis. PLoS One. 2010 Jan 6;5(1):e8604. 20062536 2797635

Di Pasqua AJ, Hong C, Wu MY, McCracken E, Wang X, Mi L, Chung FL. Sensitization of non small cell lung cancer cells to cisplatin by naturally occurring isothiocyanates. Chem Res Toxicol. 2010 Aug 16;23(8):1307-9. doi: 10.1021/tx100187f. 20707406 2924773

Erkizan HV, Uversky VN, Toretsky JA. Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma. Clin Cancer Res. 2010 Aug 15;16(16):4077-83. doi: 10.1158/1078-0432.CCR-09-2261. Epub 2010 Jun 14. 20547696

Fan S, Meng Q, Laterra JJ, Rosen EM. Scatter factor protects tumor cells against apoptosis caused by TRAIL. Anticancer Drugs. 2010 Jan;21(1):10- 24.19823077

Gan N, Wu YC, Brunet M, Garrido C, Chung FL, Dai C, Mi L. Sulforaphane activates heat shock response and enhances proteasome activity through up-regulation of Hsp27. J Biol Chem. 2010 Nov 12;285(46):35528- 36. doi:10.1074/jbc.M110.1 52686. Epub 2010 Sep 10. 20833711 2975177

Hong YB, Kang HJ, Kwon SY, Kim HJ, Kwon KY, Cho CH, Lee JM, Kallakury BV, Bae I. Nuclear factor (erythroidderived 2)-like 2 regulates drug resistance in pancreatic cancer cells. Pancreas. 2010 May;39(4):463-72. 20118824 3506252

Hou L, Chen M, Jiang B, Ng J, Hurley CK. African Americans exhibit a predominant allele in the midst of extensive KIR2DL1 allelic diversity. [Natural Killer cell reactivity] Tissue Antigens. 2010 Jul;76(1):31-4. Epub 2010 Mar 1. 20210923 3474317

Hou L, Chen M, Jiang B, Wu D, Ng J, Hurley CK. Thirty allele-level haplotypes centered around KIR2DL5 define the diversity in an African American population.[Natural Killer cell reactivity Immunogenetics. 2010 Aug;62(8):491- 8. Epub 2010 Jun 29. 20585770 3485642

Jiang W, Wang XW, Unger T, Forgues M, Kim JW, Hussain SP, Bowman E, Spillare EA, Lipsky MM, Meck JM, Cavalli LR, Haddad BR, Harris CC. Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorageindependent growth and aneuploidy in a telomeraseimmortalized normal human
hepatocyte-derived cell line Int J Cancer. 2010 Sep 1;127(5):1011- 20. 20017137 2950321

Jones LP, Sampson A, Kang HJ, Kim HJ, Yi YW, Kwon SY, Babus JK, Wang A, BaeI. Loss of BRCA1 leads to an increased sensitivity to Bisphenol A. Toxicol Lett. 2010 Dec 15;199(3):261- 8. Epub 2010 Sep 22. 20868731 3505996

Kang HJ, Hong YB, Kim HJ, Bae I. CR6-interacting factor 1 (CRIF1) regulates NF-E2- related factor 2 (NRF2) protein stability by proteasome-mediated degradation. J Biol Chem. 2010
Jul 9;285(28):21258-68. Epub 2010 Apr 28. 20427290 2898415

Krawczyk E, Suprynowicz FA, Sudarshan SR, Schlegel R. Membrane orientation of the human papillomavirus type 16 E5 oncoprotein. J Virol. 2010 Feb;84(4):1696-703. doi: 10.1128/JVI.01968- 09. Epub 2009 Dec 2. 19955310 2812368

Liu Y, Yan S, Wondimu A, Bob D, Weiss M, Sliwinski K, Villar J, Notario V, Sutherland M, Colberg- Poley AM, Ladisch S. Ganglioside synthase knockout in oncogenetransformed fibroblasts depletes gangliosides and impairs tumor growth. Oncogene. 2010 Jun 3;29(22):3297-306. doi: 10.1038/onc.2010.8 5. Epub 2010 Mar 22. 20305696 2880627

Lu C, Everhart L, Tilan J, Kuo L, Sun CC, Munivenkatappa RB, Jonsson-Rylander AC, Sun J, Kuan-Celarier A, Li L, Abe K, Zukowska Z, Toretsky JA, Kitlinska J. Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy. Oncogene. 2010 Oct 14;29(41):5630-42. Epub 2010 Aug 2. 20676138 2955165

Ma Y, Fan S, Hu C, Meng Q, Fuqua SA, Pestell RG, Tomita YA, Rosen EM. BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha. Mol Endocrinol. 2010 Jan;24(1):76- 90. Epub 2009 Nov 3. 19887647 2802901

Natarajan TG, Kallakury BV, Sheehan CE, Bartlett MB, Ganesan N, Preet A, Ross JS, Fitzgerald KT. Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon. Cancer Cell Int. 2010 Apr 30;10:13. 20433758 2878298

Nath RG, Wu MY, Emami A, Chung FL. Effects of epigallocatechin gallate, L-ascorbic acid, alpha-tocopherol, and dihydrolipoic acid on the formation of deoxyguanosine adducts derived from lipid peroxidation. Nutr Cancer. 2010;62(5): 622-9. doi: 10.1080/016355809 03532424. 20574923

Nehra R, Riggins RB, Shajahan AN, Zwart A, Crawford AC, Clarke R. BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogensensitive and -resistant breast cancer cells. FASEB J. 2010 Jun;24(6):2040-55. Epub 2010 Feb 12. 20154269 2874480

Ning Y, Riggins RB, Mulla JE, Chung H, Zwart A, Clarke R. IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis. Mol Cancer Ther. 2010 May;9(5):1274 85. 20457620 2925293

Perez RE, Knights CD, Sahu G, Catania J, Kolukula VK, Stoler D, Graessmann A, Ogryzko V, Pishvaian M, Albanese C, Avantaggiati ML. Restoration of DNA-binding and growth suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway. J Cell Physiol. 2010 Nov;225(2):394-405. doi: 10.1002/jcp.22285. 20589832

Prahalad P, Dakshanamurthy S, Ressom H, Byers SW. Retinoic acid mediates regulation of network formation by COUP-TFII and VE-cadherin expression by TGFbeta receptor kinase in breast cancer cells. PLoS One. 2010 Apr 6;5(4):e10023. 20386594 2850308

Rahimi M, George J, Tang C. EGFR variant-mediated invasion by enhanced CXCR4 expression through transcriptional and posttranslational mechanisms. Int J Cancer. 2010 Apr 15;126(8):1850- 60. 19830694 2917067

Rahimi M, Huang KL, Tang CK. 3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants. Cancer Lett. 2010 Sep 1;295(1):59-68. Epub 2010 Mar 17. 20299148 2891402

Riggins RB, Mazzotta MM, Maniya OZ, Clarke R. Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response. Endocr Relat Cancer. 2010 Aug 16;17(3):R213-31.
Print 2010 Sep. Review. 20576803 3518023

Ringer L, Sirajuddin P, Yenugonda VM, Ghosh A, Divito K, Trabosh V, Patel Y, Brophy A, Grindrod S, Lisanti MP, Rosenthal D, Brown ML, Avantaggiati ML, Rodriguez O, Albanese C. VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3- dependent apoptosis in LNCaP prostate cancer cells. Cancer Biol Ther. 2010 Aug;10(4):320- 5. Epub 2010 Aug 3. 20574155 3040852

Saha T, Rih JK, Roy R, Ballal R, Rosen EM. Transcriptional regulation of the base excision repair pathway by BRCA1. J Biol Chem. 2010 Jun 18;285(25):19092- 105. Epub 2010 Feb 25. 20185827 2885188

Saha T, Smulson M, Rosen EM. Sahab Z, Sudarshan SR, Liu X, Zhang Y, Kirilyuk A, Kamonjoh CM, Simic V, Dai Y, Byers SW, Doorbar J, Suprynowicz FA, Schlegel R. BRCA1 regulation of base excision repair pathway. Cell Cycle. 2010 Jul 1;9(13):2471-2. doi: 10.4161/cc.9.13.120 84. 20581465

Sahab ZJ, Hall MD, Zhang L, Cheema AK, Byers SW. Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26. J Cancer. 2010 Jun 2;1:14-22. 20842219 2931349

Sengupta S, Sharma CG, Jordan VC. Estrogen regulation of X-box binding protein-1 and its role in estrogen induced growth of breast and endometrial cancer cells. Horm Mol Biol Clin Investig. 2010 Aug 1;2(2):235-243. 21297881 3032413

Sikora, M.J., Rae, J.M., Johnson, M.D., Desta, Z. Efavirenz Efavirenz Directly Modulates Estrogen Receptor and Induces Breast Cancer Cell Growth. HIV Med. 2010 Oct 1;11(9):603-7. doi: 10.1111/j.1468- 1293.2010.00831.x. Epub 2010 Jun 28. 20408889 2943013

Tang Z, Varghese RS, Bekesova S, Loffredo CA, Hamid MA, Kyselova Z, Mechref Y, Novotny MV, Goldman R, Ressom HW. Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. J Proteome Res. 2010 Jan;9(1):104- 12. 19764807 2867345

Tirado OM, MacCarthy CM, Fatima N, Villar J, Mateo-Lozano S, Notario V. Caveolin-1 promotes resistance to chemotherapyinduced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation. Int J Cancer. 2010 Jan 15;126(2):426- 36. doi: 10.1002/ijc.24754 19609943 2794946

Tseng IC, Xu H, Chou FP, Li G, Vazzano AP, Kao JP, Johnson MD, Lin CY. Matriptase activation, an early cellular response to acidosis. J Biol Chem. 2010 Jan 29;285(5):3261- 70. Epub 2009 Nov 24. 19940125 2823413

Wang XY, Penalva LO, Yuan H, Linnoila RI, Lu J, Okano H, Glazer RI. Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival. Mol Cancer. 2010 Aug 21;9:221. 20727204 2939568

Wu SR, Cheng TS, Chen WC, Shyu HY, Ko CJ, Huang HP, Teng CH, Lin CH, Johnson MD, Lin CY, Lee MS. Matriptase is involved in ErbB-2-induced prostate cancer cell invasion. Am J Pathol. 2010 Dec;177(6):3145-58. Epub 2010 Oct 22. 20971737 2993294

Wynne S, Djakiew D. NSAID inhibition of prostate cancer cell migration is mediated by Nag-1 Induction via the p38 MAPK-p75(NTR) pathway. Mol CancerRes. 2010 Dec;8(12):1656-64. doi: 10.1158/1541 7786.MCR-10-0342.Epub 2010 Nov 19. 21097678 3003770

Yarden RI, Friedman E, Metsuyanim S, Olender T, Ben- Asher E, Papa MZ. Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent. Mol Carcinog. 2010 Jun;49(6):545-55. 20306497